{
  "id": "79a017b0d5f0cda7",
  "title": "Arcellx Announces New Positive Data for Its iMMagine - 1 Study in Patients with Relapsed and / or Refrac",
  "description": "20251207T024500Z",
  "content": "",
  "source": "pharmiweb.com",
  "source_url": "https://www.pharmiweb.com/press-release/2025-12-06/arcellx-announces-new-positive-data-for-its-immagine-1-study-in-patients-with-relapsed-andor-refrac",
  "published_at": "20251207T024500Z",
  "fetched_at": "2025-12-08T00:22:54.837391+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": "United States",
  "raw_data": {
    "url": "https://www.pharmiweb.com/press-release/2025-12-06/arcellx-announces-new-positive-data-for-its-immagine-1-study-in-patients-with-relapsed-andor-refrac",
    "url_mobile": "",
    "title": "Arcellx Announces New Positive Data for Its iMMagine - 1 Study in Patients with Relapsed and / or Refrac",
    "seendate": "20251207T024500Z",
    "socialimage": "https://cdn.pharmiweb.com/media/1024/1200x448-pwjobs.png",
    "domain": "pharmiweb.com",
    "language": "English",
    "sourcecountry": "United States"
  }
}